Deferred Tax Assets, Valuation Allowance of ENZO BIOCHEM INC from 31 Jul 2011 to 31 Jul 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ENZO BIOCHEM INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Jul 2011 to 31 Jul 2024.
  • ENZO BIOCHEM INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Jul 2024 was $29,662,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

ENZO BIOCHEM INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $29,662,000 +$2,977,000 +11% 31 Jul 2024 10-K 29 Oct 2024 2024 FY
Q2 2023 $26,685,000 -$7,925,000 -23% 31 Jul 2023 10-K 29 Oct 2024 2024 FY
Q2 2022 $34,610,000 +$4,736,000 +16% 31 Jul 2022 10-K 03 Nov 2023 2023 FY
Q2 2021 $29,874,000 -$203,000 -0.68% 31 Jul 2021 10-K 14 Oct 2022 2022 FY
Q2 2020 $30,077,000 +$6,550,000 +28% 31 Jul 2020 10-K 12 Oct 2021 2021 FY
Q2 2019 $23,527,000 -$944,000 -3.9% 31 Jul 2019 10-K 19 Oct 2020 2020 FY
Q2 2018 $24,471,000 -$8,110,000 -25% 31 Jul 2018 10-K 15 Oct 2019 2019 FY
Q2 2017 $32,581,000 -$2,331,000 -6.7% 31 Jul 2017 10-K 15 Oct 2018 2018 FY
Q2 2016 $34,912,000 -$14,746,000 -30% 31 Jul 2016 10-K 27 Sep 2017 2017 FY
Q2 2015 $49,658,000 +$193,000 +0.39% 31 Jul 2015 10-K 13 Oct 2016 2016 FY
Q2 2014 $49,465,000 +$1,842,000 +3.9% 31 Jul 2014 10-K 13 Oct 2015 2015 FY
Q2 2013 $47,623,000 +$6,362,000 +15% 31 Jul 2013 10-K 09 Oct 2014 2014 FY
Q2 2012 $41,261,000 +$8,341,000 +25% 31 Jul 2012 10-K 15 Oct 2013 2013 FY
Q2 2011 $32,920,000 31 Jul 2011 10-K 15 Oct 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.